anmelden
BX Swiss TOP 30 CHF
1.428,93
PKT
+17,88
PKT
+1,27
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.09.12 | Swiss Life buy | Nomura | |
| 04.09.12 | Richemont hold | Deutsche Bank AG | |
| 04.09.12 | Holcim hold | Vontobel Research | |
| 04.09.12 | Sika hold | Vontobel Research | |
| 04.09.12 | Partners Group hold | Vontobel Research | |
| 04.09.12 | Sika neutral | Sarasin Research | |
| 04.09.12 | Partners Group neutral | Sarasin Research | |
| 04.09.12 | UBS hold | ING | |
| 04.09.12 | UBS hold | ING | |
| 03.09.12 | Roche outperform | Credit Suisse Group | |
| 04.09.12 | Richemont neutral | J.P. Morgan Cazenove | |
| 03.09.12 | UBS buy | Deutsche Bank AG | |
| 03.09.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 03.09.12 | Holcim hold | Vontobel Research | |
| 03.09.12 | Novartis reduce | Vontobel Research | |
| 03.09.12 | Novartis kaufen | Die Actien-Börse | |
| 31.08.12 | Novartis buy | Deutsche Bank AG | |
| 05.09.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 31.08.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 31.08.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 31.08.12 | Holcim neutral | Citigroup Corp. | |
| 31.08.12 | Holcim sell | Citigroup Corp. | |
| 31.08.12 | UBS buy | Citigroup Corp. | |
| 31.08.12 | Roche buy | Deutsche Bank AG | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis buy | Sarasin Research | |
| 31.08.12 | Givaudan hold | Vontobel Research | |
| 30.08.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 30.08.12 | Zurich Insurance sell | Landesbank Baden-Württemberg (LBBW) | |
| 30.08.12 | Givaudan hold | Vontobel Research | |
| 30.08.12 | Novartis reduce | Vontobel Research | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 29.08.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 29.08.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 28.08.12 | Roche buy | Deutsche Bank AG | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
| 28.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
| 27.08.12 | Roche buy | Sarasin Research | |
| 27.08.12 | Novartis reduce | Vontobel Research |